These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10524573)

  • 21. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
    Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
    Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of an ultrasensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer: can the stimulation test be avoided in patients with an intermediate recurrence risk?
    Flores-Rebollar A; Pérez-Díaz I; Lagunas-Bárcenas S; García-Martínez B; Rivera-Moscoso R; Fagundo-Sierra R
    Acta Otorhinolaryngol Ital; 2018 Jun; 38(3):188-193. PubMed ID: 29984794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.
    Bourrel F; Hoff M; Regis H; Courrière P; Caron P
    Clin Chem Lab Med; 1998 Sep; 36(9):725-30. PubMed ID: 9804398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of a new IRMA for determining thyroglobulin].
    Heinze HG; Rall M
    Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
    Weightman DR; Mallick UK; Fenwick JD; Perros P
    Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
    Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
    J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.
    Smallridge RC; Meek SE; Morgan MA; Gates GS; Fox TP; Grebe S; Fatourechi V
    J Clin Endocrinol Metab; 2007 Jan; 92(1):82-7. PubMed ID: 17077133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
    Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management.
    Giovanella L; Ceriani L; Ghelfo A
    Clin Chem Lab Med; 2007; 45(11):1523-4. PubMed ID: 17892441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
    Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
    Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibodies].
    Munier P; Courtier F; Barrial K; Chikh K; Claustrat F; Le Bricon T; Bronner J; Sanabria E
    Ann Biol Clin (Paris); 2011; 69(6):721-5. PubMed ID: 22123574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroglobulin - what is the postoperative threshold for the suspicion of thyroid cancer recurrence in the absence of anti-Tg antibody measurement?
    Papageorgiou MS; Liratzopoulos N; Minopoulos G; Manolas KJ
    S Afr J Surg; 2011 Aug; 49(3):118-22. PubMed ID: 21933495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.
    Malandrino P; Latina A; Marescalco S; Spadaro A; Regalbuto C; Fulco RA; Scollo C; Vigneri R; Pellegriti G
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1703-9. PubMed ID: 21450986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
    Kloos RT; Mazzaferri EL
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5047-57. PubMed ID: 15972576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
    Stanojevic M; Savin S; Cvejic D; Djukic A; Jeremic M; Zivancević Simonovic S
    J Clin Lab Anal; 2009; 23(5):341-6. PubMed ID: 19774624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
    Giovanella L; Toffalori E; Tozzoli R; Caputo M; Ceriani L; Verburg FA
    Head Neck; 2012 Oct; 34(10):1369-71. PubMed ID: 22083639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study.
    Tortajada-Genaro LA; Cózar MP; Frigols JL; de Avila CR
    J Clin Lab Anal; 2007; 21(3):147-53. PubMed ID: 17506473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.
    Brassard M; Borget I; Edet-Sanson A; Giraudet AL; Mundler O; Toubeau M; Bonichon F; Borson-Chazot F; Leenhardt L; Schvartz C; Dejax C; Brenot-Rossi I; Toubert ME; Torlontano M; Benhamou E; Schlumberger M;
    J Clin Endocrinol Metab; 2011 May; 96(5):1352-9. PubMed ID: 21389143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?
    Rosario PW; Purisch S
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):338-42. PubMed ID: 17850379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.